• Citer

Association of trypanolytic ApoL1 variants with kidney disease in African Americans.

par Genovese, Giulio;Friedman, David J;Ross, Michael D;Lecordier, Laurence ;Uzureau, Pierrick ;Freedman, Barry I;Bowden, Donald W;Langefeld, Carl D;Oleksyk, Taras K;Uscinski Knob, Andrea L;Bernhardy, Andrea J;Hicks, Pamela J;Nelson, George W;Vanhollebeke, Benoît ;Winkler, Cheryl A;Kopp, Jeffrey B;Pays, Etienne ;Pollak, Martin R
Référence Science, 329, 5993, page (841-845)
Publication Publié, 2010-08

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Résumé :

African Americans have higher rates of kidney disease than European Americans. Here, we show that, in African Americans, focal segmental glomerulosclerosis (FSGS) and hypertension-attributed end-stage kidney disease (H-ESKD) are associated with two independent sequence variants in the APOL1 gene on chromosome 22 {FSGS odds ratio = 10.5 [95% confidence interval (CI) 6.0 to 18.4]; H-ESKD odds ratio = 7.3 (95% CI 5.6 to 9.5)}. The two APOL1 variants are common in African chromosomes but absent from European chromosomes, and both reside within haplotypes that harbor signatures of positive selection. ApoL1 (apolipoprotein L-1) is a serum factor that lyses trypanosomes. In vitro assays revealed that only the kidney disease-associated ApoL1 variants lysed Trypanosoma brucei rhodesiense. We speculate that evolution of a critical survival factor in Africa may have contributed to the high rates of renal disease in African Americans.